Entry |
|
Symbol |
PPP3CC
|
Name |
(RefSeq) serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1
|
KO |
K04348 | serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16] |
|
Organism |
lcat Lemur catta (Ring-tailed lemur)
|
Pathway |
lcat04625 | C-type lectin receptor signaling pathway |
lcat04650 | Natural killer cell mediated cytotoxicity |
lcat05022 | Pathways of neurodegeneration - multiple diseases |
lcat05166 | Human T-cell leukemia virus 1 infection |
lcat05167 | Kaposi sarcoma-associated herpesvirus infection |
lcat05170 | Human immunodeficiency virus 1 infection |
lcat05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
Brite |
KEGG Orthology (KO) [BR:lcat00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
123626515 (PPP3CC)
04310 Wnt signaling pathway
123626515 (PPP3CC)
04370 VEGF signaling pathway
123626515 (PPP3CC)
04020 Calcium signaling pathway
123626515 (PPP3CC)
04022 cGMP-PKG signaling pathway
123626515 (PPP3CC)
09140 Cellular Processes
09143 Cell growth and death
04114 Oocyte meiosis
123626515 (PPP3CC)
04218 Cellular senescence
123626515 (PPP3CC)
09150 Organismal Systems
09151 Immune system
04625 C-type lectin receptor signaling pathway
123626515 (PPP3CC)
04650 Natural killer cell mediated cytotoxicity
123626515 (PPP3CC)
04660 T cell receptor signaling pathway
123626515 (PPP3CC)
04658 Th1 and Th2 cell differentiation
123626515 (PPP3CC)
04659 Th17 cell differentiation
123626515 (PPP3CC)
04662 B cell receptor signaling pathway
123626515 (PPP3CC)
09152 Endocrine system
04922 Glucagon signaling pathway
123626515 (PPP3CC)
04921 Oxytocin signaling pathway
123626515 (PPP3CC)
04924 Renin secretion
123626515 (PPP3CC)
09156 Nervous system
04724 Glutamatergic synapse
123626515 (PPP3CC)
04728 Dopaminergic synapse
123626515 (PPP3CC)
04720 Long-term potentiation
123626515 (PPP3CC)
09158 Development and regeneration
04360 Axon guidance
123626515 (PPP3CC)
04380 Osteoclast differentiation
123626515 (PPP3CC)
09160 Human Diseases
09161 Cancer: overview
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
123626515 (PPP3CC)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
123626515 (PPP3CC)
05170 Human immunodeficiency virus 1 infection
123626515 (PPP3CC)
05163 Human cytomegalovirus infection
123626515 (PPP3CC)
05167 Kaposi sarcoma-associated herpesvirus infection
123626515 (PPP3CC)
09171 Infectious disease: bacterial
05152 Tuberculosis
123626515 (PPP3CC)
09164 Neurodegenerative disease
05010 Alzheimer disease
123626515 (PPP3CC)
05014 Amyotrophic lateral sclerosis
123626515 (PPP3CC)
05020 Prion disease
123626515 (PPP3CC)
05022 Pathways of neurodegeneration - multiple diseases
123626515 (PPP3CC)
09165 Substance dependence
05031 Amphetamine addiction
123626515 (PPP3CC)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
123626515 (PPP3CC)
09180 Brite Hierarchies
09181 Protein families: metabolism
01009 Protein phosphatases and associated proteins [BR:lcat01009]
123626515 (PPP3CC)
Enzymes [BR:lcat01000]
3. Hydrolases
3.1 Acting on ester bonds
3.1.3 Phosphoric-monoester hydrolases
3.1.3.16 protein-serine/threonine phosphatase
123626515 (PPP3CC)
Protein phosphatases and associated proteins [BR:lcat01009]
Protein serine/threonine phosphatases
Phosphoprotein phosphatases (PPPs)
Calcineurin (PPP3/ PP2B)
Catalytic subunits
123626515 (PPP3CC)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
22:22416006..22474078
|
AA seq |
519 aa
MSERRSQLSTTERVVKAVPFPPTQRLTLKEVFENGKPKVDVLKNHLIKEGRLEEEVALKI
IKDGAAILRQEKTMIEVEAPITVCGDVHGQFFDLMKLFEVGGSPSNTRYLFLGDYVDRGY
FSIECVLYLWSLKINHPKTLFLLRGNHECRHLTDYFTFKQECRIKYSEQVYDACMDTFDC
LPLAALLNQQFLCVHGGMSPEITCLDDIRRLDRFVEPPAFGPVCDLLWSDPSEDYGNEKT
LEHYTHNTVRGCSYFYSYPAVCEFLQNNNLLSIIRAHEAQDAGYRMYRKSQTTGFPSLIT
IFSAPNYLDVYNNKAAVLKYENNVMNIRQFNCSPHPYWLPNFMDVFTWSLPFVGEKVTEM
LVNILNICSDDELIDDDEEDHYISSYQKGGTTVRKEVIKNKIRAIGKMARVFSILREESE
SVLTLKGLTPTGTLPLGVLSGGKQTIETATVEAVEAREAIRGFTLPHKIRSFEEARGLDR
INERMPPRKDTVRSDGPVKSVSPVQPRALHRSDHGKKAQ |
NT seq |
1560 nt +upstreamnt +downstreamnt
atgtccgagaggcgctcccaactctccactaccgaacgcgtcgtcaaagctgtccccttt
cctccaacccaacggcttactttgaaggaagtatttgagaatgggaaacctaaagttgat
gtcttgaaaaatcatttgataaaggagggccgactagaagaggaagtggccttaaagata
atcaaggatggggctgccatcctgagacaagagaagaccatgatagaagtagaggctcca
atcacagtgtgtggtgacgttcatggacaattctttgacctgatgaagttatttgaagtt
ggaggatcaccgagtaacacgcgctacctctttctgggtgactatgtggacagaggctat
ttcagtatagagtgcgtgctgtatttatggagtttaaagattaatcatcccaaaacattg
tttctgcttcgaggaaatcatgaatgcaggcatcttacagactatttcaccttcaaacaa
gaatgtcgaataaaatattctgaacaggtgtatgatgcgtgtatggatacatttgactgt
cttcctcttgctgccctcttaaaccagcagtttctctgtgtacatggaggaatgtcacct
gaaattacttgtttagatgacattaggagattagacaggtttgttgaacctcctgccttc
gggccagtgtgtgacctgctttggtctgatccctcagaggattatggcaatgaaaagacc
ttggagcactacacccacaacactgtccgagggtgctcttacttttacagttaccctgca
gtttgtgaatttttgcagaacaataatttattatcaattatcagagcccatgaagcccaa
gatgctgggtatcgaatgtacaggaagagccaaacaacaggctttccatcacttattaca
attttctctgcccccaattacctagatgtctataacaataaagctgctgtgttgaaatat
gaaaacaatgtcatgaacatcaggcagtttaactgttctccacacccctactggcttcca
aactttatggatgttttcacatggtctttacctttcgttggggaaaaagtcacagagatg
ctggttaacattctcaacatatgctctgatgatgaactgattgatgatgatgaagaagat
cactacatttcaagctatcagaaaggaggcactacagttcgcaaggaggtcatcaagaat
aagatcagagccattgggaagatggcacgggtcttttcaattcttcgggaagagagtgag
agtgtgctgactctcaagggcctgacgcctacaggtacactccctctgggcgtcctctca
ggagggaagcagactattgagactgccacagtagaagcggtagaggcccgggaagccatc
agaggatttacacttccacacaagatccggagttttgaagaagcccgaggtctggaccga
attaatgagcgaatgccaccccgaaaagatactgtacgctctgatgggccagtgaaatct
gtaagcccggtacagccaagggctctgcacaggagcgaccatgggaagaaagcccagtaa |